Abstract
P039 - Favorable Gleason 3 + 4 prostate cancer shows comparable outcomes with Gleason 3 + 3 prostate cancer: Implications for the expansion of selection criteria for active surveillance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have